reports
Ingredion Incorporated Declares Quarterly Dividend of $0.78 per Share
Ingredion Incorporated Declares Quarterly Dividend of $0.78 per Share WESTCHESTER, Ill., May 15, 2024 (GLOBE NEWSWIRE) -- Today, the board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.78 per share on the Company’s common stock. The dividend is payable on July 23, 2024, to stockholders of record at the close of business on July 1, 2024. About the CompanyIngredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in nearly 120 countries. With 2023 annual net sale...
Robinhood Markets, Inc. Reports April 2024 Operating Data
Robinhood Markets, Inc. Reports April 2024 Operating Data MENLO PARK, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for April 2024: Funded Customers at the end of April were 24.0 million, up approximately 90 thousand from March 2024.Assets Under Custody (AUC) at the end of April were $123.3 billion, down 5% from March 2024. Net Deposits were $4.9 billion in April, translating to a 45% annualized growth rate relative to March 2024 AUC. Over the last twelve months, Net Deposits were $27.4 billion, ...
Envoy Medical Reports First Quarter 2024 Results
Envoy Medical Reports First Quarter 2024 Results The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear implant industry with its “breakthrough” fully implanted cochlear implant. WHITE BEAR LAKE, Minn., May 15, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announces its corporate and financial results for the first quarter ended March 31, 2024. Financial and Corporate...
Spero Therapeutics Announces First Quarter 2024 Operating Results and ...
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024Enrollment ongoing in PIVOT-PO, a pivotal Phase 3 clinical trial of oral tebipenem HBr in cUTIReceived FDA Fast Track designation for SPR206 for treatment of HABP/VABP due to CRABc and CRPACash balance of $82.3 million as of March 31, 2024; reiterate expected cash runway into late 2025 CAMBRIDGE, Mass., May 15, 2024 (GLOBE NEWSWI...
Snail, Inc. Reports First Quarter 2024 Financial Results
Snail, Inc. Reports First Quarter 2024 Financial Results CULVER CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its first quarter ended March 31, 2024. Tony Tian, Co-Chief Executive Officer commented, “I'm absolutely thrilled and humbled to take the helm as Co-CEO of Snail. This Company has an exceptionally talented team, ground-breaking technologies, and iconic franchises, like ARK, that have fostered pass...
Merit Medical Executive Leadership Team Update
Merit Medical Executive Leadership Team Update Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr. Wright will be responsible for the oversight of Merit’s global commercial, marketing, and manufacturing operations. Mr. Wright has been an instrumental part of the Merit team over ...
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and ...
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2024 and provides a corporate update. First Quarter 2024 Highlights Revenue in the first quarter of 2024 was $6.8 million (-11% YOY) vs. $7.6 million in the fir...
Biora Therapeutics Provides Corporate Update and Reports First Quarter...
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on device function of the NaviCap™ platform to be presented at DDW on May 19 Partnering process for the BioJet oral delivery platform is progressing well Management will host conference call and webcast today at 4:30 PM Eastern / 1:30 PM Pacific SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company...
Athira Pharma Reports First Quarter 2024 Financial Results and Pipelin...
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates Topline data from Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease expected in second half of 2024 Submitted Investigational New Drug application to U.S. Food and Drug Administration for ATH-1105 for the treatment of amyotrophic lateral sclerosis; On track to dose subjects in a first-in-human study in second quarter of 2024 Strong balance sheet to support innovative pipeline through key clinical inflection points BOTHELL, Wash., M...
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share ROSEVILLE, Minn., May 15, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 15, 2024, declared a quarterly cash dividend of $0.16 per share payable June 14, 2024, to shareholders of record at the close of business on May 31, 2024. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for...
CDT Environmental Technology Investment Holdings Limited Files Annual ...
CDT Environmental Technology Investment Holdings Limited Files Annual Report on Form 20-F Reports Second Consecutive Year of Revenue Growth and Profitability SHENZHEN, China, May 15, 2024 (GLOBE NEWSWIRE) -- CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider of waste treatment systems and services throughout China, today announces that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the “SEC”) on May 15, 2024. The annual report on Form 20-F, which co...
FormFactor Again Named One of THE BEST Suppliers in the Semiconductor ...
FormFactor Again Named One of THE BEST Suppliers in the Semiconductor Industry FormFactor Receives Five Star Rating in Annual Customer Satisfaction Survey LIVERMORE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced that it has again been named a top performer in TechInsights’ customer satisfaction survey earning five stars in three categories: 10 BEST Focused Suppliers of Chip Making Equipment,THE BEST Suppliers of Test Subsystems, andTHE BEST Suppliers of Assembly Test Equipment. In this survey,...
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provi...
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Completed in-vivo toxicology study in brown Norway rats; early results show no abnormalities at highest tested dose of RZ358 Continue to engage in productive interactions with FDA towards resolution of partial clinical holds and path forward for potential late-stage, registrational, clinical study in tumor hyperinsulinism (HI) REDWOOD ...
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Ann...
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the combined 2024 Pediatric Orthopaedic Society of North America (“POSNA”) and European Paediatric Orthopaedic Society (“EPOS”) annual meeting as an Emerald sponsor. At the Annual Meeting, the Company highlighted its growing portfolio...
Cullinan Therapeutics Provides Corporate Update and Reports First Quar...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with systemic lupus erythematosus (SLE) as the first indication Cash and investments of $434.8 million as of March 31, 2024, plus gross proceeds of $280 million from April private placement extends cash runway into 2028 Company appoints David Meek to its Board of Directors CAMBRIDGE, ...
Oncocyte Reports First Quarter 2024 Financial Results
Oncocyte Reports First Quarter 2024 Financial Results Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc.On track to ship research use only (RUO) GraftAssure™ transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD kits are under development for FDA submission....
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Pr...
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update — Second quarter fiscal 2024 revenue down 21.5% to $119.0 million— Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million— Agreement in principle reached with the U.S. Department of Justice on related matter— Site optimization projects near completion— Conference call begins today at 4:30 pm ET WEST LAFAYETTE, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery ...
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Leslie's, Inc. ("Leslie's" or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, announced that the Company has appointed Maile (Clark) Naylor to its Board of Directors, replacing Eric Kufel, effective May 15, 2024. Ms. Naylor has joined as a Class I Director and member of the Audit and Compensation Committees. Mr. Kufel has resigned from his board duties at Leslie’s to concentrate on his recently appointed ro...
Coinbase to Participate in the J.P. Morgan Global Technology, Media an...
Remote-First-Company/PORTLAND, Ore.--(BUSINESS WIRE)-- Coinbase Global, Inc. announced today that Emilie Choi, President and Chief Operating Officer, and Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the J.P. Morgan Global Technology, Media and Communications Conference on Tuesday, May 21, 2024, at 11:25 a.m. PT / 2:25 p.m. ET. A live webcast and replay of the virtual session will be available on Coinbase’s Investor Relations website at . Disclosure Information Coinbase uses the investor.coinbase.com and blog.coinbase.com websites, as well as press releases...
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s commitment to strengthening supply chain resilience and elevating the customer experience. In collaboration with a third-party logistics provider, this investment in redundancy and capacity is designed to enable QuidelOrtho to fulfill customer orders with agility. This press release features multimedia. View the full release here: QuidelOrtho opens second U.S. distribution cente...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.